About Bernie Navarro
Bernie Navarro is an executive officer at Prometheus Therapeutics.
Form D filings also name Bernie Navarro as an executive officer at NeuroFine and Deinde Medical.
Bernie Navarro first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Bernie Navarro in the role, so the role may have started earlier or lasted longer.
Prometheus Therapeutics Inc.
Executive officer
2025 – 2026 · Miramar, FL
Develops light-based treatment technology for people with vascular diseases, including brain aneurysms.
Key Colleagues at Startups
The people Bernie Navarro works with at each company, as listed on that company's latest Form D.
Prometheus Therapeutics Inc. · Form D/A, Apr 15, 2026
AH
Alexander Hastings
Director
Baruch Lieber
President & CSO, director
Ajay Wakhloo
CEO and director
JM
John McEleney
Director
NeuroFine Corp. · Form D, Apr 8, 2026
Ajay Wakhloo
Chief Executive Officer and director
JM
John McEleney
Director
DS
Daniel Sablyak
Director
ML
Marc Litzenberg
Director
Deinde Medical Corp. · Form D, Nov 12, 2025
PL
Prattipati Laxminarain
Director
Ajay Wakhloo
Director
ML
Marc Litzenberg
Chief Executive Officer and director
JM
John McEleney
Director